Table of Contents EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredient Market Report 2018 1 Active Pharmaceutical Ingredient Overview 1.1 Product Overview and Scope of Active Pharmaceutical Ingredient 1.2 Classification of Active Pharmaceutical Ingredient 1.2.1 EMEA Active Pharmaceutical Ingredient Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA Active Pharmaceutical Ingredient Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Synthetic API 1.2.4 Biotech API 1.2.5 Other 1.3 EMEA Active Pharmaceutical Ingredient Market by Application/End Users 1.3.1 EMEA Active Pharmaceutical Ingredient Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Chemical 1.3.3 Deodorant 1.3.4 Dailylife 1.4 EMEA Active Pharmaceutical Ingredient Market by Region 1.4.1 EMEA Active Pharmaceutical Ingredient Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of Active Pharmaceutical Ingredient (2013-2025) 1.5.1 EMEA Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2025) 1.5.2 EMEA Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2025) 2 EMEA Active Pharmaceutical Ingredient Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Active Pharmaceutical Ingredient Market Competition by Players/Manufacturers 2.1.1 EMEA Active Pharmaceutical Ingredient Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA Active Pharmaceutical Ingredient Revenue and Share by Players (2013-2018) 2.1.3 EMEA Active Pharmaceutical Ingredient Sale Price by Players (2013-2018) 2.2 EMEA Active Pharmaceutical Ingredient (Volume and Value) by Type/Product Category 2.2.1 EMEA Active Pharmaceutical Ingredient Sales and Market Share by Type (2013-2018) 2.2.2 EMEA Active Pharmaceutical Ingredient Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA Active Pharmaceutical Ingredient Sale Price by Type (2013-2018) 2.3 EMEA Active Pharmaceutical Ingredient (Volume) by Application 2.4 EMEA Active Pharmaceutical Ingredient (Volume and Value) by Region 2.4.1 EMEA Active Pharmaceutical Ingredient Sales and Market Share by Region (2013-2018) 2.4.2 EMEA Active Pharmaceutical Ingredient Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA Active Pharmaceutical Ingredient Sales Price by Region (2013-2018) 3 Europe Active Pharmaceutical Ingredient (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Active Pharmaceutical Ingredient Sales and Value (2013-2018) 3.1.1 Europe Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2018) 3.2 Europe Active Pharmaceutical Ingredient Sales and Market Share by Type 3.3 Europe Active Pharmaceutical Ingredient Sales and Market Share by Application 3.4 Europe Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Active Pharmaceutical Ingredient Sales Volume by Countries (2013-2018) 3.4.2 Europe Active Pharmaceutical Ingredient Revenue by Countries (2013-2018) 3.4.3 Germany Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 3.4.4 France Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 3.4.5 UK Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 3.4.6 Russia Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 3.4.7 Italy Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 3.4.8 Benelux Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 4 Middle East Active Pharmaceutical Ingredient (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Active Pharmaceutical Ingredient Sales and Value (2013-2018) 4.1.1 Middle East Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2018) 4.2 Middle East Active Pharmaceutical Ingredient Sales and Market Share by Type 4.3 Middle East Active Pharmaceutical Ingredient Sales and Market Share by Application 4.4 Middle East Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Active Pharmaceutical Ingredient Sales Volume by Countries (2013-2018) 4.4.2 Middle East Active Pharmaceutical Ingredient Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 4.4.4 Israel Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 4.4.5 UAE Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 4.4.6 Iran Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 5 Africa Active Pharmaceutical Ingredient (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Active Pharmaceutical Ingredient Sales and Value (2013-2018) 5.1.1 Africa Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2018) 5.2 Africa Active Pharmaceutical Ingredient Sales and Market Share by Type 5.3 Africa Active Pharmaceutical Ingredient Sales and Market Share by Application 5.4 Africa Active Pharmaceutical Ingredient Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Active Pharmaceutical Ingredient Sales Volume by Countries (2013-2018) 5.4.2 Africa Active Pharmaceutical Ingredient Revenue by Countries (2013-2018) 5.4.3 South Africa Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 5.4.4 Nigeria Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 5.4.5 Egypt Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 5.4.6 Algeria Active Pharmaceutical Ingredient Sales and Growth Rate (2013-2018) 6 EMEA Active Pharmaceutical Ingredient Manufacturers/Players Profiles and Sales Data 6.1 Teva 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Teva Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Novartis 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Novartis Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Pfizer 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Johnson & Johnson 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Mylan 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Mylan Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 North China Pharmaceutical Group 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Dr. Reddy’s Laboratories 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Roche 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Roche Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Aurobindo pharma 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Sun Pharmaceutical Industries 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Active Pharmaceutical Ingredient Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Boehringer Ingelheim GmbH 6.12 Bayer 6.13 BASF 6.14 DSM 6.15 Zhejiang Medicine 6.16 Biocon 6.17 Johnson Matthey 6.18 Hisun Pharmacy 6.19 Cambrex 6.20 Shandong Xinhua Pharmaceutical 6.21 Lonza group 6.22 Huahai Pharmaceutical 6.23 Haerbin Pharmaceutical Group 6.24 Cipla 6.25 Tian Yao 6.26 Lupin 6.27 North East Pharmaceutical 6.28 Albemarle 6.29 Shandong Lukang Pharmaceutical 6.30 Jiangsu　Hengrui Medicine 7 Active Pharmaceutical Ingredient Manufacturing Cost Analysis 7.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Active Pharmaceutical Ingredient Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Active Pharmaceutical Ingredient Market Forecast (2018-2025) 11.1 EMEA Active Pharmaceutical Ingredient Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA Active Pharmaceutical Ingredient Price and Trend Forecast (2018-2025) 11.2 EMEA Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA Active Pharmaceutical Ingredient Sales Forecast by Type (2018-2025) 11.7 EMEA Active Pharmaceutical Ingredient Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Active Pharmaceutical Ingredient Figure EMEA Active Pharmaceutical Ingredient Sales Volume (K MT) by Type (2013-2025) Figure EMEA Active Pharmaceutical Ingredient Sales Volume Market Share by Type (Product Category) in 2017 Figure Synthetic API Product Picture Figure Biotech API Product Picture Figure Other Product Picture Figure EMEA Active Pharmaceutical Ingredient Sales Volume (K MT) by Application (2013-2025) Figure EMEA Sales Market Share of Active Pharmaceutical Ingredient by Application in 2017 Figure Chemical Examples Table Key Downstream Customer in Chemical Figure Deodorant Examples Table Key Downstream Customer in Deodorant Figure Dailylife Examples Table Key Downstream Customer in Dailylife Figure EMEA Active Pharmaceutical Ingredient Market Size (Million USD) by Region (2013-2025) Figure Europe Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries Figure Middle East Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries Figure Africa Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa Active Pharmaceutical Ingredient Revenue (Million USD) Status and Forecast by Countries Figure EMEA Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2013-2025) Figure EMEA Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA Active Pharmaceutical Ingredient Market Major Players Product Sales Volume (K MT) (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales Volume (K MT) of Major Players (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales Share by Players (2013-2018) Figure 2017 Active Pharmaceutical Ingredient Sales Share by Players Figure 2017 Active Pharmaceutical Ingredient Sales Share by Players Figure EMEA Active Pharmaceutical Ingredient Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA Active Pharmaceutical Ingredient Revenue (Million USD) by Players (2013-2018) Table EMEA Active Pharmaceutical Ingredient Revenue Share by Players (2013-2018) Table 2017 EMEA Active Pharmaceutical Ingredient Revenue Share by Players Table 2017 EMEA Active Pharmaceutical Ingredient Revenue Share by Players Table EMEA Active Pharmaceutical Ingredient Sale Price (USD/MT) by Players (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Type (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales Share by Type (2013-2018) Figure Sales Market Share of Active Pharmaceutical Ingredient by Type (2013-2018) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share by Type (2013-2018) Table EMEA Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA Active Pharmaceutical Ingredient Revenue Share by Type (2013-2018) Figure Revenue Market Share of Active Pharmaceutical Ingredient by Type in 2017 Table EMEA Active Pharmaceutical Ingredient Sale Price (USD/MT) by Type (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Application (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales Share by Application (2013-2018) Figure Sales Market Share of Active Pharmaceutical Ingredient by Application (2013-2018) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share by Application in 2017 Table EMEA Active Pharmaceutical Ingredient Sales (K MT) and Market Share by Region (2013-2018) Table EMEA Active Pharmaceutical Ingredient Sales Share by Region (2013-2018) Figure Sales Market Share of Active Pharmaceutical Ingredient by Region (2013-2018) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share in 2017 Table EMEA Active Pharmaceutical Ingredient Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA Active Pharmaceutical Ingredient Revenue Share by Region (2013-2018) Figure Revenue Market Share of Active Pharmaceutical Ingredient by Region (2013-2018) Figure EMEA Active Pharmaceutical Ingredient Revenue Market Share Regions in 2017 Table EMEA Active Pharmaceutical Ingredient Sales Price (USD/MT) by Region (2013-2018) Figure Europe Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2013-2018) Table Europe Active Pharmaceutical Ingredient Sales (K MT) by Type (2013-2018) Table Europe Active Pharmaceutical Ingredient Market Share by Type (2013-2018) Figure Europe Active Pharmaceutical Ingredient Market Share by Type in 2017 Table Europe Active Pharmaceutical Ingredient Sales (K MT) by Application (2013-2018) Table Europe Active Pharmaceutical Ingredient Market Share by Application (2013-2018) Figure Europe Active Pharmaceutical Ingredient Market Share by Application in 2017 Table Europe Active Pharmaceutical Ingredient Sales (K MT) by Countries (2013-2018) Table Europe Active Pharmaceutical Ingredient Sales Market Share by Countries (2013-2018) Figure Europe Active Pharmaceutical Ingredient Sales Market Share by Countries (2013-2018) Figure Europe Active Pharmaceutical Ingredient Sales Market Share by Countries in 2017 Table Europe Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2013-2018) Table Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Europe Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2017 Figure Germany Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure France Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure UK Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Russia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Italy Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Benelux Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East Active Pharmaceutical Ingredient Sales (K MT) by Type (2013-2018) Table Middle East Active Pharmaceutical Ingredient Market Share by Type (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Market Share by Type (2013-2018) Table Middle East Active Pharmaceutical Ingredient Sales (K MT) by Applications (2013-2018) Table Middle East Active Pharmaceutical Ingredient Market Share by Applications (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Sales Market Share by Application in 2017 Table Middle East Active Pharmaceutical Ingredient Sales Volume (K MT) by Countries (2013-2018) Table Middle East Active Pharmaceutical Ingredient Sales Volume Market Share by Countries (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Sales Volume Market Share by Countries in 2017 Table Middle East Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2013-2018) Table Middle East Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Middle East Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2017 Figure Saudi Arabia Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Israel Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure UAE Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Iran Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Africa Active Pharmaceutical Ingredient Revenue (Million USD) and Growth Rate (2013-2018) Table Africa Active Pharmaceutical Ingredient Sales (K MT) by Type (2013-2018) Table Africa Active Pharmaceutical Ingredient Sales Market Share by Type (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales Market Share by Type (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales Market Share by Type in 2017 Table Africa Active Pharmaceutical Ingredient Sales (K MT) by Application (2013-2018) Table Africa Active Pharmaceutical Ingredient Sales Market Share by Application (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales Market Share by Application (2013-2018) Table Africa Active Pharmaceutical Ingredient Sales Volume (K MT) by Countries (2013-2018) Table Africa Active Pharmaceutical Ingredient Sales Market Share by Countries (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales Market Share by Countries (2013-2018) Figure Africa Active Pharmaceutical Ingredient Sales Market Share by Countries in 2017 Table Africa Active Pharmaceutical Ingredient Revenue (Million USD) by Countries (2013-2018) Table Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries (2013-2018) Figure Africa Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2017 Figure South Africa Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Nigeria Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Egypt Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Algeria Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Table Teva Active Pharmaceutical Ingredient Basic Information List Table Teva Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Teva Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Teva Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Teva Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Novartis Active Pharmaceutical Ingredient Basic Information List Table Novartis Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Novartis Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Novartis Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Novartis Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Pfizer Active Pharmaceutical Ingredient Basic Information List Table Pfizer Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Pfizer Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Pfizer Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Pfizer Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Johnson & Johnson Active Pharmaceutical Ingredient Basic Information List Table Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Johnson & Johnson Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Johnson & Johnson Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Mylan Active Pharmaceutical Ingredient Basic Information List Table Mylan Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Mylan Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Mylan Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Mylan Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information List Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Basic Information List Table Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Roche Active Pharmaceutical Ingredient Basic Information List Table Roche Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Roche Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Roche Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Roche Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Aurobindo pharma Active Pharmaceutical Ingredient Basic Information List Table Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Aurobindo pharma Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Aurobindo pharma Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Basic Information List Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018) Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate (2013-2018) Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales Market Share in EMEA (2013-2018) Figure Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue Market Share in EMEA (2013-2018) Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Basic Information List Table Bayer Active Pharmaceutical Ingredient Basic Information List Table BASF Active Pharmaceutical Ingredient Basic Information List Table DSM Active Pharmaceutical Ingredient Basic Information List Table Zhejiang Medicine Active Pharmaceutical Ingredient Basic Information List Table Biocon Active Pharmaceutical Ingredient Basic Information List Table Johnson Matthey Active Pharmaceutical Ingredient Basic Information List Table Hisun Pharmacy Active Pharmaceutical Ingredient Basic Information List Table Cambrex Active Pharmaceutical Ingredient Basic Information List Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Basic Information List Table Lonza group Active Pharmaceutical Ingredient Basic Information List Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Basic Information List Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Basic Information List Table Cipla Active Pharmaceutical Ingredient Basic Information List Table Tian Yao Active Pharmaceutical Ingredient Basic Information List Table Lupin Active Pharmaceutical Ingredient Basic Information List Table North East Pharmaceutical Active Pharmaceutical Ingredient Basic Information List Table Albemarle Active Pharmaceutical Ingredient Basic Information List Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Basic Information List Table Jiangsu　Hengrui Medicine Active Pharmaceutical Ingredient Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredient Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient Figure Active Pharmaceutical Ingredient Industrial Chain Analysis Table Raw Materials Sources of Active Pharmaceutical Ingredient Major Manufacturers in 2017 Table Major Buyers of Active Pharmaceutical Ingredient Table Distributors/Traders List Figure EMEA Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate Forecast (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Price (USD/MT) and Trend Forecast (2018-2025) Table EMEA Active Pharmaceutical Ingredient Sales (K MT) Forecast by Region (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share Forecast by Region (2018-2025) Table EMEA Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Revenue Market Share Forecast by Region (2018-2025) Table Europe Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2018-2025) Figure Europe Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2018-2025) Table Europe Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2018-2025) Table Middle East Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2018-2025) Figure Middle East Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2018-2025) Table Middle East Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2018-2025) Table Africa Active Pharmaceutical Ingredient Sales (K MT) Forecast by Countries (2018-2025) Figure Africa Active Pharmaceutical Ingredient Sales Market Share Forecast by Countries (2018-2025) Table Africa Active Pharmaceutical Ingredient Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa Active Pharmaceutical Ingredient Revenue Market Share Forecast by Countries (2018-2025) Table EMEA Active Pharmaceutical Ingredient Sales (K MT) Forecast by Type (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share Forecast by Type (2018-2025) Table EMEA Active Pharmaceutical Ingredient Sales (K MT) Forecast by Application (2018-2025) Figure EMEA Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources